Site navigation

Navigation

Rheumatoid arthritis (refractory) - abatacept

Abatacept for the treatment of rheumatoid arthritis

Summary

Abatacept is not recommended for people with moderate to severe active rheumatoid arthritis who have already tried drugs known as disease-modifying anti-rheumatic drugs (including a 'TNF inhibitor'drug), which didn't work or weren't suitable.Healthcare professionals should not stop prescribing abata ...

Read the complete summary


Guidance documents

Implementing this guidance

We will consult on our review plans for this guidance in July 2010

About this guidance

Technology appraisals TA141

Issued: April 2008

See related guidance:

See this guidance in practice:

Order printed copies of this guidance